KTTA fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. Steinman on May 12, 2020 and is headquartered in Miami Beach, FL.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
KTTA has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company